Academic Journal

Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer

التفاصيل البيبلوغرافية
العنوان: Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer
المؤلفون: Daniel J. García-Domínguez, Soledad López-Enríquez, Gonzalo Alba, Carmen Garnacho, Carlos Jiménez-Cortegana, Rocío Flores-Campos, Luis de la Cruz-Merino, Nabil Hajji, Víctor Sánchez-Margalet, Lourdes Hontecillas-Prieto
المصدر: International Journal of Molecular Sciences, Vol 25, Iss 2, p 1195 (2024)
بيانات النشر: MDPI AG
سنة النشر: 2024
المجموعة: Directory of Open Access Journals: DOAJ Articles
مصطلحات موضوعية: cancer, immunotherapy, nanomedicine, clinical trials, Biology (General), QH301-705.5, Chemistry, QD1-999
الوصف: Cancer is a complex disease that, despite advances in treatment and the greater understanding of the tumor biology until today, continues to be a prevalent and lethal disease. Chemotherapy, radiotherapy, and surgery are the conventional treatments, which have increased the survival for cancer patients. However, the complexity of this disease together with the persistent problems due to tumor progression and recurrence, drug resistance, or side effects of therapy make it necessary to explore new strategies that address the challenges to obtain a positive response. One important point is that tumor cells can interact with the microenvironment, promoting proliferation, dissemination, and immune evasion. Therefore, immunotherapy has emerged as a novel therapy based on the modulation of the immune system for combating cancer, as reflected in the promising results both in preclinical studies and clinical trials obtained. In order to enhance the immune response, the combination of immunotherapy with nanoparticles has been conducted, improving the access of immune cells to the tumor, antigen presentation, as well as the induction of persistent immune responses. Therefore, nanomedicine holds an enormous potential to enhance the efficacy of cancer immunotherapy. Here, we review the most recent advances in specific molecular and cellular immunotherapy and in nano-immunotherapy against cancer in the light of the latest published preclinical studies and clinical trials.
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 1422-0067
1661-6596
Relation: https://www.mdpi.com/1422-0067/25/2/1195; https://doaj.org/toc/1661-6596; https://doaj.org/toc/1422-0067; https://doaj.org/article/61ae30b5083743feb8847aabd49c9e8a
DOI: 10.3390/ijms25021195
الاتاحة: https://doi.org/10.3390/ijms25021195
https://doaj.org/article/61ae30b5083743feb8847aabd49c9e8a
رقم الانضمام: edsbas.45870CAE
قاعدة البيانات: BASE
الوصف
تدمد:14220067
16616596
DOI:10.3390/ijms25021195